VisEn Launches Molecular Imaging Agent

VisEn Medical Inc., a leader in fluorescence in vivo imaging from research through medicine, announced the commercial launch of its new ReninSense680 FAST imaging agent for measuring and monitoring a key hypertension and renal disease biomarker in vivo.
CNBC